Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic Sources
在随机 II 期临床试验中使用两种不同抗原来源生成治疗级树突状细胞的协调方案的优化和验证
期刊:Vaccines
影响因子:
doi:10.3390/vaccines12020112
Abirami Seetharaman, Vasanth Christopher, Hemavathi Dhandapani, Hascitha Jayakumar, Manikandan Dhanushkodi, Narmadha Bhaskaran, Swaminathan Rajaraman, Rama Ranganathan, Shirley Sunder Singh, Varalakshmi Vijayakumar, Arivazhagan Rajamanickam, Anil Suri, Nirmala Jagadish, Thangarajan Rajkumar, Priya R